Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

410
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

286
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
286
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

553
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
553
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

433
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

438
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
438
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

309
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
309

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A deep learning model to dynamically predict cancer-associated thromboembolism in large-scale healthcare systems.

NPJ digital medicine·2026
Same author

Performance Evaluation of a Novel Non-Invasive Monitoring Device for At-Home Neutropenia Detection in a Multicenter Cancer Cohort.

American journal of hematology·2026
Same author

Performance of open-source large language models on nephrology self-assessment program.

medRxiv : the preprint server for health sciences·2026
Same author

Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2.

Blood vessels, thrombosis & hemostasis·2026
Same author

The podocyte slit-diaphragm: target of anti-nephrin antibodies.

Current opinion in nephrology and hypertension·2026
Same author

Hematopoietic JAK2V617F mutation-induced reprogramming of blood and bone marrow megakaryocytes.

Blood advances·2026

Related Experiment Video

Updated: Feb 26, 2026

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

18.0K

Thrombotic Microangiopathy: A Multidisciplinary Team Approach.

Craig E Gordon1, Vipul C Chitalia1, J Mark Sloan2

  • 1Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|July 20, 2017
PubMed
Summary

A new interdisciplinary Thrombotic Microangiopathy (TMA) team improves patient care by streamlining diagnosis and treatment. This collaborative approach also advances research into the causes of TMA, enhancing overall management strategies.

Keywords:
Thrombotic microangiopathy (TMA)clinical carecomplement-mediated hemolytic uremic syndrome (CM-HUS)hematologymultidisciplinary teamnephrologyrare disorderthrombotic thrombocytopenic purpura (TTP)translational research

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

10.3K

Related Experiment Videos

Last Updated: Feb 26, 2026

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

18.0K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

10.3K

Area of Science:

  • Hematology
  • Clinical Medicine
  • Translational Research

Background:

  • Thrombotic microangiopathy (TMA) presents with microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction.
  • Delayed diagnosis and treatment initiation are common due to TMA's rarity and varied presentation.
  • Interdisciplinary collaboration is crucial for effective TMA management.

Purpose of the Study:

  • To describe a novel interdisciplinary team approach for improving clinical management of TMA.
  • To establish a collaborative framework for advancing translational research in TMA.
  • To enhance awareness and education of front-line providers regarding TMA.

Main Methods:

  • Formation of a dedicated TMA team with faculty from diverse clinical disciplines.
  • Development of a clinical database and biorepository for TMA research.
  • Educational outreach to front-line providers across various specialties.

Main Results:

  • The TMA team facilitates rapid clinical assessment, laboratory guidance, and prompt treatment initiation.
  • The established infrastructure supports collaborative efforts to understand TMA pathogenesis.
  • Educational initiatives aim to improve early recognition and management by a wider range of clinicians.

Conclusions:

  • An interdisciplinary TMA team, supported by research infrastructure, can significantly improve clinical care.
  • This collaborative model enhances both patient management and the understanding of TMA.
  • Effective communication and education are key to optimizing TMA treatment and research outcomes.